Supha Pharmachem Limited (BOM:539561)

Market Cap	185.47M -78.2%
Revenue (ttm)	5.27B -84.3%
Net Income	122.54M -49.2%
EPS	0.19 -53.8%
Shares Out	403.20M
PE Ratio	2.46
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,774,433
Average Volume	7,890,661
Open	0.4600
Previous Close	0.4400
Day's Range	0.4600 - 0.4600
52-Week Range	0.3200 - 1.9400
Beta	1.30
RSI	49.94
Earnings Date	Mar 30, 2026

About Supha Pharmachem

Supha Pharmachem Limited, a pharmaceutical company, trades and sells active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, iodine, selenium meta...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1988
• Employees: 7
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539561

Financial Performance

In fiscal year 2025, Supha Pharmachem's revenue was 4.05 billion, a decrease of -89.97% compared to the previous year's 40.42 billion. Earnings were 21.29 million, a decrease of -93.49%.